Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantation.

Abstract:

:Milky spots (MS), peritoneal lymphoid tissues, expose the extracellular matrix (ECM) due to a defect of mesothelial cells on their surface, which may explain why peritoneal implantation of cancer cells preferentially takes place at MS. We recently reported that adenovirus vector-mediated intraperitoneal production of NK4 strongly suppressed MS-selective implantation of cancer cells and subsequent peritoneal dissemination, without histological evidence of angiogenesis inhibition. The present study was conducted to clarify the mechanisms underlying the suppressive effects of NK4 on peritoneal implantation. In mice intraperitoneally injected with CT26 cells that were genetically modified to produce NK4 (CT26-NK4), peritoneal dissemination was significantly suppressed with survival prolongation. A decreased cell implantation to omental MS was also detected and evaluated by green fluorescence protein (GFP) imaging. In an in vitro adhesion assay, hepatocyte growth factor-stimulated adhesion to ECM components, such as fibronectin and collagen, was inhibited in CT26-NK4 compared to control cells. These results strongly suggest an inhibition of cancer cell adhesion to the ECM in the suppression of peritoneal implantation by NK4.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Yoshimura M,Fujiwara H,Kubota T,Amaike H,Takashima K,Inada S,Atsuji K,Araki Y,Matsumoto K,Nakamura T,Yamagishi H

subject

Has Abstract

pub_date

2005-11-01 00:00:00

pages

3847-54

issue

6B

eissn

0250-7005

issn

1791-7530

journal_volume

25

pub_type

杂志文章
  • Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.

    abstract:BACKGROUND:Previously we demonstrated that injection of Interleukin-alpha (IL-1) stimulated B16 melanoma tumour growth in vivo, associated with increased intercellular adhesion molecule-1 (ICAM-1) expression on the tumour cells (Photodermatol Photoimmunol Photomed 1994; 10: 74-79, ). METHODS:In the present study, we e...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: McKenzie RC,Oran A,Dinarello CA,Sauder DN

    更新日期:1996-01-01 00:00:00

  • A phase-II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer.

    abstract:BACKGROUND:Both liposomal doxorubicin (LD) and docetaxel (D) have a broad range of activity against solid tumors, including advanced pancreatic cancer (APC), as single agents, while their combination has produced encouraging response rates in the treatment of several malignancies. We have conducted a Phase-II study in ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Syrigos KN,Michalaki B,Alevyzaki F,Machairas A,Mandrekas D,Kindilidis K,Karatzas G

    更新日期:2002-11-01 00:00:00

  • In vivo inhibition by antioxidants of adriamycin-induced apoptosis in murine peritoneal macrophages.

    abstract::Adriamycin (ADM) is an oncostatic of the anthracycline family with confirmed experimental and clinical efficiency. This antitumoral drug has been reported to stimulate macrophage activity and is able to induce apoptosis (AP) in some tumour cells. The objective of the present work was to investigate if in vivo administ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Dominguez-Rodriguez JR,Gomez-Contreras PC,Hernandez-Flores G,Lerma-Diaz JM,Carranco A,Cervantes-Munguia R,Orbach-Arbouys S,Bravo-Cuella A

    更新日期:2001-05-01 00:00:00

  • Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.

    abstract:BACKGROUND:Adjuvant immunotherapy with interferon alpha in non-metastatic RCC is still controversial. It was the aim of the present study to investigate whether tumor ploidy can help to isolate a group of patients profitting from this treatment. MATERIALS AND METHODS:Survival data of 119 patients undergoing tumor neph...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Basting R,Corvin S,Händel D,Hinke A,Schmidt D

    更新日期:1999-03-01 00:00:00

  • Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results.

    abstract::Adoptive immunotherapy in cancer has been essentially restricted to the use of lymphoid effector cells (NK, TIL, LAK) stimulated with IL-2. Differentiated macrophages represent another key effector population even more important for the immune control of cancer. We have shown that activated murine macrophages reduced ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bartholeyns J,Lopez M,Andreesen R

    更新日期:1991-05-01 00:00:00

  • Multicenter evaluation of the Elecsys CA 125 II assay.

    abstract::The technical performance and clinical usefulness of the newly developed Elecsys CA 125 II assay (Boehringer Mannheim) was evaluated in a multicenter study. Imprecision studies were carried out using control sera and human pool sera with CA 125 concentrations from 11 to 1026 U/ml. Within-run CVs between 0.7 to 4.8% (m...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Hubl W,Chan DW,Van Ingen HE,Miyachi H,Molina R,Filella X,Pitzel L,Ruibal A,Rymer JC,Bagnard G,Domke I

    更新日期:1999-07-01 00:00:00

  • Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative Surgery.

    abstract:BACKGROUND/AIM:Glioma-associated oncogene 1 (GLI1) is an important transcription factor in the hedgehog signalling pathway and tumour formation. We evaluated the clinical significance of GLI1 expression as a prognostic factor in patients with locally advanced gastric cancer (GC). PATIENTS AND METHODS:GLI1 expression l...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14599

    authors: Hashimoto I,Oue N,Kimura Y,Hiroshima Y,Hara K,Maezawa Y,Kano K,Fujikawa H,Aoyama T,Numata M,Yamada T,Tamagawa H,Yamamoto N,Ogata T,Shiozawa M,Morinaga S,Rino Y,Yasui W,Masuda M,Miyagi Y,Oshima T

    更新日期:2020-10-01 00:00:00

  • Y-box Binding Protein 1 Is Involved in Regulating the G2/M Phase of the Cell Cycle.

    abstract:BACKGROUND/AIM:The transcription factor Y-box-binding protein 1 (YB1) is overexpressed in many types of human cancers. YB1 regulates the G1 phase of the cell cycle by controlling transcription of G1 regulators. Here, we report that YB1 is also involved in regulating G2/M phase. MATERIALS AND METHODS:YB1-depleted TKO c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11490

    authors: Kotake Y,Arikawa N,Tahara K,Maru H,Naemura M

    更新日期:2017-04-01 00:00:00

  • Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer.

    abstract::Single agent carboplatin has demonstrated antitumoral activity in patients with advanced breast cancer. Thirty patients with inoperable locally advanced and/or metastatic breast cancer were treated with carboplatin (300 mg/m2) in combination with cyclophosphamide (600 mg/m2) and 5-fluorouracil (500 mg/m2) given on day...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Closon MT,Verbeke L,Kains JP,Tijtgat J,Schallier D

    更新日期:1995-03-01 00:00:00

  • A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer.

    abstract:BACKGROUND:Acquired resistance to platinum-based chemotherapy (Pt-chemo) is a major problem for improving the prognosis for patients with advanced epithelial ovarian cancer (EOC). However, the molecular mechanism of acquired resistance to Pt-chemo is not well understood. MATERIALS AND METHODS:hMLH1 promoter methylatio...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Watanabe Y,Ueda H,Etoh T,Koike E,Fujinami N,Mitsuhashi A,Hoshiai H

    更新日期:2007-05-01 00:00:00

  • A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.

    abstract::Interleukin-2 (IL-2) has proven to be able to generate an effective anticancer immunity against both solid and hematologic malignancies. Moreover, recent advances in the knowledge of psychoneuroimmunology have demonstrated that anticancer immunity is under neuroendocrine control and that the pineal hormone melatonin (...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Lissoni P,Bolis S,Brivio F,Fumagalli L

    更新日期:2000-05-01 00:00:00

  • Long-term survivors after chemotherapy in advanced non-small cell lung cancer.

    abstract:BACKGROUND:Chemotherapy is considered to have a marginal impact on survival. The purpose of this study was to evaluate the rate of long-term survival in patients treated with chemotherapy for advanced non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:The case records of 109 patients with NSCLC treated with chem...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Satoh H,Ishikawa H,Ohara G,Kagohashi K,Kurishima K,Ohtsuka M,Hizawa N

    更新日期:2007-11-01 00:00:00

  • Cancer cell growth and extracellular matrix remodeling mechanism of ascorbate; beneficial modulation by P. leucotomos.

    abstract::Ascorbate has dose-dependent inverse effects on cancer cells growth and expression of matrixmetalloproteinases (MMP) and transforming growth factor-beta (TGF-beta), which regulate extracellular matrix (ECM) remodeling. We examined melanoma cell viability and ECM remodeling mechanisms of ascorbate and its modulation by...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Philips N,Dulaj L,Upadhya T

    更新日期:2009-08-01 00:00:00

  • Zinc concentrations in serum during head and neck cancer progression.

    abstract:UNLABELLED:Reduced serum-zinc concentrations are well known as typical laboratory characteristics in advanced head and neck cancer. Our aim was to follow the development of this phenomenon during the disease. PATIENTS AND METHODS:A total of 21 patients were included in this pilot-study (1 female, 20 male). The median ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Büntzel J,Bruns F,Glatzel M,Garayev A,Mücke R,Kisters K,Schäfer U,Schönekaes K,Micke O

    更新日期:2007-07-01 00:00:00

  • Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression.

    abstract:BACKGROUND:Human neuroblastoma and medulloblastoma express abnormal ganglioside patterns especially GD2 and GM2 which are important for tumour growth. We tested the effects of L-cycloserine (L-CS), a potent inhibitor of synthesis of glycosphingolipids, on the growth, viability and expression of GD2 and GM2 in neuroblas...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cinatl J Jr,Cinatl J,Kotchetkov R,Pouckova P,Vogel JU,Rabenau H,Michaelis M,Kornhuber B

    更新日期:1999-11-01 00:00:00

  • Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.

    abstract::VEGF is an important angiogenic cytokine with a critical role in tumor angiogenesis. VEGF concentrations were measured using an ELISA assay, detecting VEGF165 isoform, in tumor cyst and/or ascitic fluids and in sera of 86 patients with malignant neoplasms and in 53 patients with benign ovarian neoplasms. VEGF levels w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Harlozinska A,Sedlaczek P,Kulpa J,Grybos M,Wójcik E,Van Dalen A,Einarsson R

    更新日期:2004-03-01 00:00:00

  • Clinical significance of the Rb expression in adenocarcinoma of the lung.

    abstract:BACKGROUND:Altered retinoblastoma gene expression has been found in various types of cancers including non-small cell lung cancer (NSCLC) and some reports have shown it also to be associated with a poor clinical prognosis in NSCLC. MATERIALS AND METHODS:We evaluated the expression of Rb protein by immunohistochemistry...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sugio K,Tsukamoto S,Ushijima C,Yamazaki K,Kase S,Yamaguchi M,Ondo K,Yano T,Sugimachi K

    更新日期:2001-05-01 00:00:00

  • Surgical treatment of early gastric cancer.

    abstract::Our investigation comprises 778 cases of resection for early gastric cancer (27.4% of all stomach resections). The rate of lymph node metastasis was 1.2% in m (mucosal cancer) group, 3.3% in sm (submucosal cancer) 1 group and 22.6% in sm 2 group. In sm 2 group, lymph node extirpation of R2 is essential. The five year ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kito T,Yamamura Y,Kobayashi S

    更新日期:1988-05-01 00:00:00

  • Selective usage of TCR V beta in tumor-specific CTL lines isolated from ovarian tumor-associated lymphocytes.

    abstract::We have developed a series of six CTL lines exhibiting preferential killing of autologous tumour cells from tumour-associated lymphocytes (TALs) infiltrating malignant ovarian ascites. Five out of six CTL lines showed increased percentages of V beta 8.1+ cells, four showed increased percentages of V beta 5.3+ cells an...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ioannides CG,Freedman RS

    更新日期:1991-09-01 00:00:00

  • Effect of lipoprotein lipase activators bezafibrate and NO-1886, on B16 melanoma-induced cachexia in mice.

    abstract::Our recent study has demonstrated that B16 melanoma-induced cachexia in mice is inhibited by ponalrestat, an aldose reductase inhibitor, which has the ability to activate lipoprotein lipase (LPL) activity both in vitro and in vivo. In this study, the effect of bezafibrate and NO-1886, LPL activators, on B16 melanoma-i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawamura I,Yamamoto N,Sakai F,Yamazaki H,Goto T

    更新日期:1999-09-01 00:00:00

  • STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.

    abstract::Eosinophil granulocytes have been implicated in anticancer immunity but recent data indicate that eosinophils can also promote cancer. Herein, we studied eosinophils in skin lesions from 43 patients with mycosis fungoides (MF). The presence of eosinophils correlated with disease stage: 78% of patients with advanced di...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fredholm S,Gjerdrum LM,Willerslev-Olsen A,Petersen DL,Nielsen IØ,Kauczok CS,Wobser M,Ralfkiaer U,Bonefeld CM,Wasik MA,Krejsgaard T,Geisler C,Ralfkiaer E,Gniadecki R,Woetmann A,Odum N

    更新日期:2014-10-01 00:00:00

  • The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.

    abstract:BACKGROUND:Zoledronic acid is a new member of the bisphosphonate (BP) class of compounds, a family of closely related synthetic molecules originally derived from the naturally occurring pyrophosphate. These compounds that are potent inhibitors of bone resorption, have been shown to reduce the growth of several cancer c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bäckman U,Svensson A,Christofferson RH,Azarbayjani F

    更新日期:2008-05-01 00:00:00

  • Intracellular localization of tenascin in squamous cell carcinoma of oral cavity: an immunohistochemical study.

    abstract::Tenascin is a multifunctional extracellular matrix glycoprotein generally expressed in epithelial tumors at sites of epithelial tumor-mesenchymal tissue interface. Studies so far have indicated that mesenchymal cells are a major source of tenascin in tumor tissues. The present study evaluated biopsies and surgically r...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mori M,Muramatsu Y,Yamada K,Shrestha P,Takai Y

    更新日期:1996-09-01 00:00:00

  • Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade.

    abstract::Colorectal cancers with high microsatellite instability (MSI-H) have distinct clinical features in terms of their prognosis, recurrence patterns, and sensitivity to immunotherapeutic agents. We present the case of a woman with a left-sided MSI-H colon cancer who had repeated recurrences concentrated exclusively in the...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11739

    authors: Greene C,Nakakura EK,Ko AH

    更新日期:2017-07-01 00:00:00

  • Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer.

    abstract:BACKGROUND:We report the prognostic significance of peripheral and tumor-infiltrating Th1, Th2, Tc1 and Tc2 cells in lung cancer patients. MATERIALS AND METHODS:We evaluated the rates of interferon (IFN)-gamma+/CD4+ cells (Th1), interleukin (IL)-4+ /CD4+ cells (Th2), IFN-gamma+/CD8+ cells (Tc1), IL-4+ /CD8+ cells (Tc2...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ito N,Suzuki Y,Taniguchi Y,Ishiguro K,Nakamura H,Ohgi S

    更新日期:2005-05-01 00:00:00

  • Biological characteristics of a newly established human cervical carcinoma cell line.

    abstract::A new cell line, designated CC2/CUHK2, was established from a squamous carcinoma of the uterine cervix from a Chinese patient. The cell line grew well without interruption for over 12 months and over 90 passages. The doubling time of CC2/CUHK2 was 72 hours at passage 57. When seeded at a density of 1.5 x 10(3) cells p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ho TH,Chew EC,Tam JS,Hou HJ,Yam HF,Chew-Cheng SB,Wong FW

    更新日期:1993-07-01 00:00:00

  • Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: case report.

    abstract:BACKGROUND:Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. CASE:A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Maruyama M,Asano T,Kenmochi T,Kainuma O,Iwasaki K,Miyauchi H,Saigo K,Miura F,Kobayashi S,Ochiai T

    更新日期:2003-05-01 00:00:00

  • Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

    abstract:BACKGROUND:Several studies have demonstrated the efficacy of systemic oxaliplatin (Oxa) in combination with 5-fluorouracil (5-FU) and folinic acid (FA) for the treatment of colorectal liver metastases (CRLM). However, nothing is presently known about the pharmacokinetics of Oxa administered via the hepatic artery and o...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Guthoff I,Lotspeich E,Fester C,Wallin I,Schatz M,Ehrsson H,Kornmann M

    更新日期:2003-11-01 00:00:00

  • Pentafecta Outcomes of 230 Cases of Robotic-assisted Radical Prostatectomy with Bilateral Neurovascular Bundle Preservation.

    abstract:AIM:We analyzed pentafecta outcomes [complication-free, continence, potency, negative surgical margins (NSM)], biochemical recurrence (BCR)-free] of 230 patients undergoing robotic-assisted radical prostatectomy (RARP) with bilateral neurovascular (NVB) preservation. PATIENTS AND METHODS:Patient outcomes (group I, cas...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ou YC,Yang CK,Kang HM,Chang KS,Wang J,Hung SW,Tung MC,Tewari AK,Patel VR

    更新日期:2015-09-01 00:00:00

  • Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment.

    abstract:BACKGROUND:Several attempts have been made to determine whether interphase fluorescence in situ hybridization (I-FISH) on bone marrow or peripheral blood specimens is a good alternative to conventional cytogenetics (CC) in calculating the residual proportion of Philadelphia (Ph) chromosome-positive cells during treatme...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Douet-Guilbert N,Morel F,Le Charpentier T,Le Bris MJ,Herry A,Morice P,Bourquard P,Abgrall JF,Berthou C,De Braekeleer M

    更新日期:2004-07-01 00:00:00